Infective endocarditis

Handbook of Clinical Neurology

Volumn 119, Issue , 2014, Pages 75-91

  Ferro, José M ^a   Fonseca, Ana Catarina ^a  

^a UNIVERSITY OF LISBON   (Portugal)

Author keywords

Anticoagulation; Embolism; Encephalopathy; Endocarditis; Mycotic aneurysm; Stroke; Valve surgery

Indexed keywords

ANTICOAGULATION; ARTICLE; BRAIN DISEASE; CEREBROVASCULAR ACCIDENT; EMBOLISM; ENDOCARDITIS; HUMAN; MYCOTIC ANEURYSM; NEUROLOGIC DISEASE; RHEUMATIC HEART DISEASE; VALVE SURGERY;

ANTICOAGULATION; EMBOLISM; ENCEPHALOPATHY; ENDOCARDITIS; MYCOTIC ANEURYSM; STROKE; VALVE SURGERY;

ENDOCARDITIS; HUMANS; NERVOUS SYSTEM DISEASES; RHEUMATIC HEART DISEASE;

EID: 84890877206     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-7020-4086-3.00007-2     Document Type: Chapter

References (119)

1. Ahmadi J., Tung H., Giannotta S.L., et al. Monitoring of infectious intracranial aneurysms by sequential computed tomographic/magnetic resonance imaging studies. Neurosurgery 1993, 32:45-49.
2. Anavekar N.S., Tleyjeh I.M., Anavekar N.S., et al. Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. Clin Infect Dis 2007, 44:1180-1186.
3. Anderson D.J., Goldstein L.B., Wilkinson W.E., et al. Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis. Neurology 2003, 61:1341-1346.
4. Angswurm K., Borges A.C., Halle E., et al. Timing the valve replacement in infective endocarditis involving the brain. J Neurol 2004, 251:1220-1226.
5. Autret A., Saudeua D., de Toffol B. Neurological complications of endocarditis. Handbook of Clinical Neurology 1993, vol. 19:111-129. Elsevier, Amsterdam, (63). C.G. Goetz, C.M. Tanner, M.J. Aminoff (Eds.).
6. Azuma A., Toyoda K., O'uchi T. Brain magnetic resonance findings in infective endocarditis with neurological complications. Jpn J Radiol 2009, 27:123-130.
7. Baddour L.M., Wilson W.R., Bayer A.S., et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005, 111:e394-e434.
8. Baddour L.M., Epstein A.E., Erickson C.C., et al. Update on cardiovascular implantable electronic device infections and their management. A scientific statement from the American Heart Association. Circulation 2010, 121:458-477.
9. Bamfort J., Hodges J., Warlow C. Late rupture of a mycotic aneurysm after "cure" of bacterial endocarditis. J Neurol 1986, 233:51-53.
10. Baravelli M., Rossi A., Picozzi A., et al. A case of Guillain-Barré syndrome following Staphylococcus aureus endocarditis. Int J Cardiol 2007, 114:e53-e55.
11. Bertonini T.E., Laster R.E., Thompson B.F., et al. Magnetic resonance imaging of the brain in bacterial endocarditis. Arch Intern Med 1989, 149:815-817.
12. Beynon R.P., Bahl V.K., Prendergast B.D. Infective endocarditis. BMJ 2006, 333:334-339.
13. Bhuva P., Kuo S.-H., Hemphill J.C., et al. Intracranial hemorrhage following thrombolytic use for stroke caused by infective endocarditis. Neurocrit Care 2010, 12:79-82.
14. Bingham W.F. Treatment of intracranial mycotic aneurysms. J Neurosurg 1977, 46:428-437.
15. Bohmfalk G.L., Story J.L., Wissinger J.P., et al. Bacterial intracranial aneurysms. J Neurosurg 1978, 1978:369-382.
16. Cabell C.H., Pond K.K., Peterson G.E., et al. The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J 2001, 154:1086-1094.
17. Chan K.L., Dumesnil J.G., Cujec B., et al. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol 2003, 42:775-780.
18. Chan K.L., Tam J., Dumesnil J.G., et al. Effects of long-term aspirin use on embolic events in infective endocarditis. Clin Infect Dis 2008, 46:37-41.
19. Chapot R., Houdart E., Saint-Maurice J.P., et al. Endovascular treatment of cerebral mycotic aneurisms. Radiology 2002, 222:389-396.
20. Chu V.H., Cabell C.H., Benjamin D.K., et al. Early predictors of in-hospital death in infective endocarditis. Circulation 2004, 109:1745-1749.
21. Chun J.Y., Smith W., Halbach V.V., et al. Current multimodality management of infectious intracranial aneurisms. Neurosurgery 2001, 48:1203-1214.
22. Cone L.A., Hirschberg J., Lopez C., et al. Infective endocarditis associated with spondylodiscitis and frequent secondary epidural abscess. Surg Neurol 2008, 69:121-125.
23. Cooper H.A., Thompson E.C., Laureno R., et al. Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses (EMBOLISM) pilot study. Circulation 2009, 120:585-591.
24. Corr P., Wright M., Handler L.C. Endocarditis-related cerebral aneurysms: radiologic changes with treatment. AJNR Am J Neuroradiol 1995, 16:745-748.
25. Corral I., Martín-Dávila P., Fortún J., et al. Trends in neurological complications of endocarditis. J Neurol 2007, 254:1253-1259.
26. Delahaye F., Alla F., Beguinot I., et al. In-hospital mortality of infective endocarditis: prognostic factors and evolution over an 8-year period. Scand J Infect Dis 2007, 39:849-857.
27. Dhomne S., Rao C., Shrivastava M., et al. Endovascular management of ruptured cerebral mycotic aneuryms. Br J Neurosurg 2008, 22:46-52.
28. Di Salvo G., Habib G., Pergola V., et al. Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 2001, 2001:1069-1076.
29. Dickerman S.A., Abrutyn E., Barsic B., et al. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J 2007, 154:1086-1094.
30. Ducruet A.F., Hickman Z.L., Zacharia B.D., et al. Intracranial infectious aneurysms: a comprehensive review. Neurosurg Rev 2010, 33:37-46.
31. Durack D.T., Lukes A.S., Bright D.K. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994, 96:200-209.
32. Durante Mangoni E., Adinolfi L.E., Tripodi M.F., et al. Risk factors for "major" embolic events in hospitalized patients with infective endocarditis. Am Heart J 2003, 146:311-316.
33. Duval X., Iung B., Klien I., et al. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann Intern Med 2010, 152:497-504.
34. Eisen D.P., Corey G.R., McBryde E.S., et al. Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid. J Infect 2009, 58:332-338.
35. Eishi K., Kawazoe K., Kuriyama Y., et al. Surgical management of infective endocarditis associated with cerebral complications. Multicenter retrospective study in Japan. J Thorac Cardiovasc Surg 1995, 110:1745-1755.
36. Epaulard O., Roch N., Potton L., et al. Infective endocarditis-related stroke: diagnostic delay and prognostic factors. Scand J Infect Dis 2009, 41:558-562.
37. Erbel R., Liu F., Ge J., et al. Identification of high-risk subgroups in infective endocarditis and the role of echocardiography. Eur Heart J 1995, 16:588-602.
38. European Agency for the Evaluation of Medicinal Products, Committee for Proprietary Medicinal Products Summary information on a referral opinion following an arbitration pursuant to article 29 of Directive 2001/83/EC, for Actilyse 2002, CPNP/3346/02-EN.
39. Fabri J., Issa V.S., Pomerantzeff P.M., et al. Time-related distribution, risk factors and prognostic influence of embolism I patients with left-sided endocarditis. Int J Cardiol 2006, 110:334-339.
40. Fernández-Ruiz M., López-Medrano F., García-Montero M., et al. Intramedullary cervical spinal cord abscess by viridans group Streptococcus secondary to infective endocarditis and facilitated by previous local radiotherapy. Intern Med 2009, 48:61-64.
41. Gillinov A.M., Shah R.V., Curtis W.E., et al. Valve replacement in patients with endocarditis and acute neurologic deficit. Ann Thorac Surg 1996, 61:1125-1129.
42. Greaves K., Mou D., Patel A. Clinical criteria and the appropriate use of transthoracic echocardiography for the exclusion of infective endocarditis. Heart 2003, 89:273-275.
43. Habib H. The 2009 ESC Guidelines for management of infective endocarditis reviewed. Eur Heart J 2009, 30:2285-2294.
44. Habib G., Hoen B., Tornos P., et al. The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 2009, 30:2369-2413.
45. Hart R.G., Foster J.W., Luther M.F., et al. Stroke in infective endocarditis. Stroke 1990, 21:695-700.
46. Hasbun R., Vikram H.R., Barakat L.A., et al. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA 2003, 289:1933-1940.
47. Heiro M., Nikoskelainen J., Engblom E., et al. Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med 2000, 160:2781-2787.
48. Hoen B., Alla F., Selton-Suty C., et al. Changing profile of infective endocarditis: results of a 1 year survey in France. JAMA 2002, 288:75-81.
49. Hsu R.-B., Lin F.-Y. Methicillin resistance and risk factors for embolism in Staphylococcus aureus infective endocarditis. Infect Control Hosp Epidemiol 2007, 28:860-866.
50. Huston J., Nichols D.A., Luetmer P.H., et al. Blinded prospective evaluation of sensitivity of MR angiography to know intracranial aneurysms: importance of aneurysm size. AJNR Am J Neuroradiol 1994, 15:1607-1614.
51. Jault F., Gandjbakhch I., Rama A., et al. Active native valve endocarditis: determinants of operative death and late mortality. Ann Thorac Surg 1997, 63:1737-1741.
52. Jones H.R., Siekert R.G., Geraci J.E. Neurologic manifestations of bacterial endocarditis. Ann Intern Med 1969, 71:21-28.
53. Junna M., Lin C.C., Espinosa R.E., et al. Successful intravenous thrombolysis in ischemic stroke caused by infective endocarditis. Neurocrit Care 2007, 6:117-120.
54. Kang D.H., Kim Y.J., Kim S.H., et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 2012, 366:2466-2473.
55. Kannoth S., Thomas S.V. Intracranial microbial aneurysm (infectious aneurysm): current options for diagnosis and management. Neurocrit Care 2009, 11:120-129.
56. Kannoth S., Iyer R., Thomas S.V., et al. Intracranial infectious aneurysm: presentation, management and outcome. J Neurol Sci 2007, 256:3-9.
57. Kiyan S., Aksay E., Ersel M., et al. A rare diagnosis in ED: cerebral pyogenic ventriculitis due to infective endocarditis. Am J Emerg Med 2007, 25:120-122.
58. Klein I., Iung B., Labreuche J., et al. Cerebral microbleeds are frequent in infective endocarditis: a case-control study. Stroke 2009, 40:3461-3465.
59. Kupferwasser L.I., Yeaman M.R., Shapiro S.M., et al. Acetylsalicylic acid reduces vegetation bacterial density, hematogeneous bacterial disseminations, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation 1999, 99:2791-2799.
60. Kupferwasser L.I., Yeaman M.R., Nast C.C., et al. Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus. J Clin Invest 2003, 112:222-233.
61. Lepur D., Barsic B. Incidence of neurological complications in patients with native-valve infective endocarditis and cerebral microembolism: an open cohort study. Scand J Infect Dis 2009, 41:708-713.
62. Levy D.M. Centenary of William Osler's 1885 Gulstonian Lectures and their place in the history of bacterial endocarditis. J R Soc Med 1985, 78:1039-1046.
63. Levy D.M. Gustav Mahler and Emmanuel Libman: bacterial endocarditis in 1911. BMJ 1986, 293:20-27.
64. Li J.S., Sexton D.J., Mick N., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-638.
65. Mansur A.J., Grinberg M., Cardoso R.H., et al. Determinants of prognosis in 300 episodes of infective endocarditis. Thorac Cardiovasc Surg 1996, 44:2-10.
66. Moreillon P., Que Y.-A. Infective endocarditis. Lancet 2004, 363:139-149.
67. Mugge A., Daniel W.G., Frank G., et al. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol 2003, 14:631-638.
68. Mulleman D., Philippe P., Senneville E., et al. Streptococcal and enterococcal spondylodiscitis (vertebral osteomyelitis). High incidence of infective endocarditis in 50 cases. J Rheumatol 2006, 33:91-97.
69. Murdoch D.R., Corey G.R., Hoen B., et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century. The International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009, 169:463-473.
70. Mylonakis E., Calderwood S.B. Infective endocarditis in adults. N Eng J Med 2001, 345:1318-1330.
71. Nadji G., Rémadi J.P., Coviaux F., et al. Comparison of clinical and morphological characteristics of Staphyloccocus aureus endocarditis with endocarditis caused by other pathogens. Heart 2005, 91:932-937.
72. National Institute for Health and Clinical Excellence, Short Clinical Guidelines Technical Team Prophylaxis against infective endocarditis: antimicrobial prophylaxis in adults and children undergoing interventional procedures. NICE Clinical Guideline 64 2008, London: NICE 2008. http://www.nice.org.uk/CG64.
73. Netzer R.O., Altwegg S.C., Zolinger E., et al. Infective endocarditis determinants of long term outcome. Heart 2002, 88:61-66.
74. Nishimura R.A., Carabello B.A., Faxon D.P., et al. AAC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 52:676-685.
75. Oliver R., Roberts G.J., Hooper L., et al. Antibiotics for the prophylaxis of bacterial endocarditis in dentistry. Cochrane Database Syst Rev 2008, CD003813.
76. Osler W. The Gulstonian Lectures, on malignant endocarditis. BMJ 1885, 1:467-470. 522-526, 577-579.
77. Parize P., Mainardi J.-L. Les actualités dans l'endocardite infectieuse. Rev Med Interne 2011, 32:612-621.
78. Paschalis C., Pugsley W., John R., et al. Rate of cerebral embolic events in relation to antibiotic and anticoagulant therapy in patients with bacterial endocarditis. Eur Neurol 1990, 30:87-89.
79. Pepin J., Trembley V., Behcard D., et al. Chronic antiplatelet therapy and mortality among patients with infective endocarditis. Clin Microbiol Infect 2009, 15:193-199.
80. Pérez de Isla L., Zamorano J., Lennie V., et al. Negative blood culture infective endocarditis in the elderly: long-term follow-up. Gerontology 2007, 53:245-249.
81. Pergola V., Di Salvo G., Habib G., et al. Comparison of clinical an echocardiographic characteristics of Streptococcuc bovis endocarditis with that caused by other pathogens. Am J Cardiol 2001, 88:871-875.
82. Peters P.J., Harrison T., Lennox J.L. A dangerous dilemma: management of infectious intracranial aneurysms complicating endocarditis. Lancet Infect Dis 2006, 6:742-748.
83. Piper C., Wiemer M., Schulte H.D., et al. Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis. J Heart Valve Dis 2001, 10:703-711.
84. Prendergast B.D. Diagnostic criteria and problems in infective endocarditis. Heart 2004, 90:611-613.
85. Prendergast B.D. The changing face of infective endocarditis. Heart 2006, 92:879-885.
86. Prendergast B.D., Tornos P. Surgery for infective endocrditis. Who and when?. Circulation 2010, 121:1141-1152.
87. Que Y.A., Haefliger J.A., Piroth L., et al. Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J Exp Med 2005, 201:1627-1635.
88. Rasmussen R.V., Snygg-Martin U., Olaison L., et al. Major cerebral events in Staphyloccocus aureus infective endocarditis: is anticoagulant therapy safe?. Cardiology 2009, 114:284-291.
89. Roder B.L., Wandall D.A., Espersen F., et al. Neurologic manifestations in Staphylococcus aureus endocarditis: a review of 260 bacteremic cases in non drug addicts. Am J Med 1997, 102:379-386.
90. Rohmann S., Erbel R., Darius H., et al. Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size. J Am Soc Echocardiogr 1991, 4:465-474.
91. Rohmann S., Erbel Gorge G., et al. Clinical relevance of vegetation localization by transesophageal echocardiography in infective endocarditis. Eur Heart J 1992, 13:446-452.
92. Ruttman E., Willeit J., Ulmer H., et al. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke 2006, 37:2094-2099.
93. Salem D.N., O'Gara P.T., Madias C., et al. Valvular and structural heart disease. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, 8th edn. Chest 2008, 133(6 Suppl):593S-629S.
94. Salgado A.V. Central nervous system complications of infective endocarditis. Stroke 1991, 26:19-22.
95. Salgado A.V., Furlan A.J., Keyes T.F. Mycotic aneurysms, subarachnoid hemorrhage and indications for cerebral angiography in infective endocarditis. Stroke 1987, 18:1057-1060.
96. Salgado A.V., Furlan A.J., Keys T.F., et al. Neurologic complications of endocarditis: a 12-year experience. Neurology 1989, 39:173-178.
97. San Roman J.A., Lopez J., Vilacosta I., et al. Prognostic stratification of patients with left sided endocarditis determined at admission. Am J Med 2007, 120(369):e1-e7.
98. Sanfilippo A.J., Picard M.H., Newell J.B., et al. Echocardiographic assessment of patients with infective endocarditis: prediction of risk of complications. J Am Coll Cardiol 1991, 18:1191-1199.
99. Shang E., Forrest G.N., Chizmar T., et al. Mitral valve infective endocarditis: benefit of early operation and aggressive use of repair. Ann Thorac Surg 2009, 87:1728-1734.
100. Sila C.A. Neurological complications of bacterial endocarditis. Handbook of Clinical Neurology (3rd series) 2010, Vol. 96:221-229. Elsevier, Amsterdam. K.L. Roos, A.R. Tunkel (Eds.).
101. Snygg-Martin U., Gustafsson L., Rosengren L., et al. Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis 2008, 47:23-30.
102. Strom B.L., Abrutyn E., Berlin J.A., et al. Risk factors for infective endocarditis: oral hygiene and nondental exposures. Circulation 2000, 102:2842-2848.
103. Takanashi J.-I., Hirasawa K.-I., Tada H. Reversible restricted diffusion of the entire corpus callosum. J Neurol Sci 2006, 247:101-104.
104. Tan M., Armstrong D., Birken C., et al. Bacterial endocarditis in a child presenting with acute arterial ischemic stroke: should thrombolytic therapy be absolutely contraindicated?. Dev Med Child Neurol 2009, 51:151-154.
105. Thuny F., Habib G. When should we operate on patients with acute infective endocarditis?. Heart 2010, 96:892-897.
106. Thuny F., Disalvo G., Belliard O., et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography. A prospective multicenter study. Circulation 2005, 112:69-75.
107. Thuny F., Avierinos J.F., Tribouilloy C., et al. Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. Eur Heart J 2007, 28:1155-1161.
108. Tischler M.D., Vaitkus P.T. The ability of vegetation size on echocardiography to predict clinical complications: a meta-analysis. J Am Soc Echocardiogr 1997, 10:562-568.
109. Tleyjeh I.M., Abdel-Latif A., Rahib H., et al. A systematic review of population-based studies of infective endocarditis. Chest 2007, 132:1025-1035.
110. Tornos P., Almirante Mirabet S., et al. Infective endocarditis due to Staphylococcus aureus: deleterious effects of anticoagulant therapy. Arch Intern Med 1999, 159:473-475.
111. Tornos P., Lung B., Permayer-Miralda G., et al. Infective endocarditis in Europe: lessons from the Euro Heart Survey. Heart 2005, 91:571-575.
112. Tsai T.N., Lee J.T., Hsu Y.D., et al. Trigeminal neuralgia as a presentation of infective endocarditis. Int J Clin Pract 2008, 62:830-832.
113. Vilacosta I., Graupner C., San Roman J.A., et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol 2002, 39:1489-1495.
114. Wajnberg E., Rueda F., Marchiori E., et al. Endovascular treatment for intracranial infectious aneurysms. Arq Neuropsiquiatr 2008, 66:790-794.
115. Wallace S.M., Walton B.I., Kharbanda R.K., et al. Mortality from infective endocarditis: clinical predictors of outcome. Heart 2002, 88:61-66.
116. White P.M., Teasdale Wardlaw J.M., et al. Intracranial aneurysms: CT angiography and MR angiography for detection: prospective blinded comparison in a large patient cohort. Radiology 2001, 219:739-749.
117. Wilson W.R., Giuliani E.R., Danielson G.K., et al. Management of complications of infective endocarditis. Mayo Clin Proc 1982, 1982:162-170.
118. Yavasoglu I., Kadikoylu G., Bolaman Z., et al. Spondylodiscitis and Streptoccus viridans endocarditis. J Natl Med Assoc 2005, 97:1722-1724.
119. Zahr F., Katz W.E., Toyoda Y., et al. Late bacterial endocarditis of an Amplatzer atrial septal defect occluder device. Am J Cardiol 2010, 105:279-280.